123
Views
13
CrossRef citations to date
0
Altmetric
Research Article

LAPTM4B gene polymorphism and endometrial carcinoma risk and prognosis

, , , , &
Pages 136-143 | Received 28 Jul 2012, Accepted 20 Nov 2012, Published online: 11 Jan 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mohammad Hashemi, Maryam Rezaei, Behzad Narouie, Nasser Simforoosh, Abbas Basiri, Sayed Amir Mohsen Ziaee, Gholamreza Bahari & Mohsen Taheri. (2016) Association between LAPTM4B gene polymorphism and prostate cancer susceptibility in an Iranian population. Molecular & Cellular Oncology 3:6.
Read now

Articles from other publishers (12)

Gholamreza Bahari, Mohammad Hashemi, Mohsen Taheri & Majid Naderi. (2020) Assocition between LAPTM4B gene polymorphism and the risk of childhood acute lymphoblastic leukemia. Koomesh Journal 22:1, pages 67-70.
Crossref
Mohammad Hashemi, Gholamreza Bahari, Farhad Tabasi, Jarosław Markowski, Andrzej Małecki, Saeid Ghavami & Marek J. Łos. (2018) LAPTM4B gene polymorphism augments the risk of cancer: Evidence from an updated meta-analysis. Journal of Cellular and Molecular Medicine 22:12, pages 6396-6400.
Crossref
Huirong Ding, Xiaojing Cheng, Ning Ding, Zhihua Tian, Jun Zhu, Chunlian Zhou, Jing Shen & Yuqin Song. (2017) Association between LAPTM4B gene polymorphism and susceptibility to and prognosis of diffuse large B‑cell lymphoma. Oncology Letters.
Crossref
Yue Meng, Rouli Zhou, Jianjun Xu & Qingyun Zhang. (2017) LAPTM4B*2 allele is associated with the development of papillary thyroid carcinoma in Chinese women. Oncology Letters 14:3, pages 3421-3428.
Crossref
Y Meng, L Wang, D Chen, Y Chang, M Zhang, J-J XU, R Zhou & Q-Y Zhang. (2016) LAPTM4B: an oncogene in various solid tumors and its functions. Oncogene 35:50, pages 6359-6365.
Crossref
Xiaojing Cheng, Xiuyun Tian, Xiaojiang Wu, Xiaofang Xing, Hong Du, Chunlian Zhou, Qingyun Zhang, Chunyi Hao, Xianzi Wen & Jiafu Ji. (2016) Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers. PLOS ONE 11:7, pages e0158715.
Crossref
Ling-Zi Xia, Zhi-Hua Yin, Yang-Wu Ren, Li Shen, Wei Wu, Xue-Lian Li, Peng Guan & Bao-Sen Zhou. (2015) The relationship between LAPTM4B polymorphisms and cancer risk in Chinese Han population: a meta-analysis. SpringerPlus 4:1.
Crossref
Cuiju Mo, Yu Lu, Yan Deng, Jian Wang, Li Xie, Taijie Li, Yu He, Qiliu Peng, Xue Qin & Shan Li. (2014) LAPTM4B polymorphism increases susceptibility to multiple cancers in Chinese populations: a meta-analysis. BMC Genetics 15:1.
Crossref
Mohammad Hashemi, Sahadi Amininia, Mahboubeh Ebrahimi, Seyed Mehdi Hashemi, Javad Yousefi, Ebrahim Eskandari-Nasab, Mohsen Taheri & Saeid Ghavami. (2014) Association between LAPTM4B gene polymorphism and breast cancer susceptibility in an Iranian population. Medical Oncology 31:8.
Crossref
Han Tang, Hui Tian, Weiming Yue, Lin Li, Shuhai Li, Cun Gao, Libo Si, Lei Qi, Ming Lu & Wensi Hu. (2014) LAPTM4B polymorphism is associated with non‑small cell lung cancer susceptibility and prognosis. Oncology Reports.
Crossref
Xavier Matias-Guiu & Ben Davidson. (2014) Prognostic biomarkers in endometrial and ovarian carcinoma. Virchows Archiv 464:3, pages 315-331.
Crossref
Shuren Zhang. (2013) LAPTM4B‑35 protein is a weak tumor‑associated antigen candidate. Experimental and Therapeutic Medicine.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.